The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - GenesisCare Australia
Stock and Other Ownership Interests - Clarity Pharmaceuticals; Telix Pharmaceutricals
Honoraria - Oncobeta GmbH
Research Funding - Ariceum (Inst); Full-Life Technologies (Inst); Telix Pharmaceutricals (Inst)
A first-in-human, phase 1 dose escalation and expansion study evaluating the safety, tolerability, and anti-tumor activity of [225Ac]Ac-FL-020, an anti-PSMA radioconjugate, in patients with metastatic castration-resistant prostate cancer (mCRPC).
 
Andrei Iagaru
Consulting or Advisory Role - Alpha9Tx; Clarity Pharmaceuticals; Isotopen Technologien; Lilly; Novartis; Radionetics; Telix Pharmaceuticals
Research Funding - Advanced Accelerator Applications (Inst); GE Healthcare (Inst); Progenics (Inst)
Travel, Accommodations, Expenses - GE Healthcare
 
Giuseppe Cardaci
No Relationships to Disclose
 
Aaron Hansen
Consulting or Advisory Role - Astellas Pharma; Bayer; Eisai; Janssen; Merck
Research Funding - Advancell (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Macrogenics (Inst); Merck (Inst); Roche/Genentech (Inst); Seagen (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer
 
Jeffrey Wong
Travel, Accommodations, Expenses - Accuray
 
Carlos Artigas
Consulting or Advisory Role - Bayer; Telix Pharmaceuticals
 
Karolien Goffin
Consulting or Advisory Role - Bayer; GE Healthcare; Telix Pharmaceuticals
Research Funding - Bayer (Inst); Novartis (Inst); Telix Pharmaceuticals (Inst)
 
Rafael Villanueva-Vázquez
Consulting or Advisory Role - AstraZeneca; Seagen
Travel, Accommodations, Expenses - AstraZeneca Spain; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Novartis
 
Daniel Castellano Gauna
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Novartis; Pfizer; Roche
 
Felix Mottaghy
Consulting or Advisory Role - Novartis; Telix Pharmaceuticals
Research Funding - Blue Earth Diagnostics (Inst); GE Healthcare (Inst); Radiopharm Theranostics (Inst); Siemens (Inst)
 
Anne Robert
Employment - Full-Life Technologies
Stock and Other Ownership Interests - Novartis
 
Jing Zhao
Employment - Full-Life Technologies
 
Juan Zhang
Employment - Full-Life Technologies
Stock and Other Ownership Interests - CStone Pharmaceuticals
 
Steffen Heeger
Employment - Full-Life Technologies
Stock and Other Ownership Interests - Centessa Pharmaceuticals; Full-Life Technologies; Phoenix Biopharma Co.
Consulting or Advisory Role - Phoenix Biopharma Co.
 
Karl Schumacher
Employment - Full-Life Technologies GmbH
Stock and Other Ownership Interests - Full-Life Technologies GmbH; Tolremo Therapeutics AG
 
Ken Herrmann
Leadership - Aktis Oncology; Pharma15
Stock and Other Ownership Interests - AdvanCell; Aktis Oncology; Convergent Therapeutics; SOFIE
Consulting or Advisory Role - Advanced Accelerator Applications; Amgen; AstraZeneca; Bain Capital; Bayer; Boston Scientific; BTG; Debiopharm Group; Fusion Pharmaceuticals; GE Healthcare; Immedica; IPSEN; ITG (Inst); Janssen Oncology; Molecular Partners; Novartis; Radiopharm Theranostics; ROTOP Pharmaka (Inst); Siemens Healthineers; Telix Pharmaceuticals